Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs

National
1 August 2014 12:19



North West/North Wales
1 August 2014 12:12



Midlands
1 August 2014 12:10


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
Zenopa, you have done it again! By 'it' I mean you have supported my application to a great company where so far, I feel like I fit right in.
Natasha, 2013

Hormone discovery linked to stroke recovery benefits

18 May 2011 00:00 in Scientific Developments/Breakthroughs


A hormone associated with the body's growth hormone system could play a role in helping stroke patients to make a more effective recovery.

Researchers from the Sahlgrenska Academy at the University of Gothenburg have linked the blood-borne hormone insulin-like growth factor I (IGF-I) to better long-term recovery following a stroke, based on research involving 407 patients.

This was the first study to show that IGF-I - which contributes to growth and bone mass and is found in abundance among healthy, active patients - can have positive effects long after the stroke event among those with high levels of the hormone during early phases.

It is hoped that this could lead to the development of stroke treatment methods that use the hormone itself or stimulate its production.

Associate professor David Aberg at the Sahlgrenska Academy said: "Of course, these possibilities must be tested in carefully constructed clinical trials, so that we discover any undesired effects that must be considered."

Last month, the University of Leicester conducted research showing that neutralising a certain enzyme in the body can also help to minimise damage following ischaemic events such as heart attacks and strokes.ADNFCR-8000103-ID-800548326-ADNFCR

Other news stories from 18/05/2011

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd